Understanding how communication between patients and providers affects cancer treatment outcomes
Quantifying patient-provider communication using machine learning to assess its impact on metastatic cancer patients' outcomes
This study is looking at how good communication between cancer patients and their doctors can help patients stick to their oral treatments better, using technology to understand how they talk to each other and improve their interactions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11109737 on NIH RePORTER |
What this research studies
This research investigates the role of patient-provider communication in the treatment of metastatic cancer patients, focusing on how effective communication can improve adherence to oral therapies. By utilizing machine learning to analyze secure messaging data between patients and healthcare providers, the study aims to quantify communication patterns and their impact on patient outcomes. The goal is to enhance the quality of interactions, thereby fostering trust and improving adherence rates to cancer treatments. Patients will be engaged through digital health platforms to facilitate timely communication about their treatment needs and concerns.
Who could benefit from this research
Good fit: Ideal candidates for this research are metastatic cancer patients who are undergoing oral therapy treatments.
Not a fit: Patients who are not currently receiving oral cancer therapies or those with early-stage cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved adherence to cancer therapies and better overall health outcomes for patients.
How similar studies have performed: Previous research has shown that enhancing patient-provider communication can lead to better health outcomes, indicating a promising avenue for this approach.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Jarad, Samah Jamal Fodeh — Yale University
- Study coordinator: Jarad, Samah Jamal Fodeh
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.